Skip to content

Effect of integrated focused renal supportive care on quality of life of kidney disease patients on hemodialysis.

Effect of Integrated Focused Renal Supportive Care on Symptom Burden, Quality of Life and Advance care planning in End stage Renal disease Patients: A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/034179
Enrollment
542
Registered
2021-06-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N186- End stage renal disease

Interventions

Intervention1: Integrated Renal Supportive care: Patients in this arm with receive additional integrated renal supportive care services (intervention under study) by palliative care team. Patient in t

Sponsors

ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: For phase 1 All ESRD patients who are more than 18 years old visiting the hospital Patient Caregiver Inclusion criteria Who are older than 18 years Primary caregiver cared for at least 6 month Nephrology Team Inclusion Criteria Dialysis technicians dialysis nurses clinical faculties nephrologists who are involved in the care of ESRD patients for at least 12 months For phase 2 Patients fulfilling the following criteria will be eligible for Phase II Patient who are more than 18 years with a score

Exclusion criteria

Exclusion criteria: For phase 1 Acute kidney injury patient in a tertiary care hospital A patient who is unable to complete questionnaires A patient caregiver who is unable to complete questionnaires Those who are not willing to give consent

Design outcomes

Primary

MeasureTime frame
Quality of life and Symptom burden among End stage renal disease patients. The number of patients and caregivers with knowledge of advanced care planning. The factors related to acceptance or unwillingness for ACP discussions. Timepoint: 3 year

Secondary

MeasureTime frame
Change in quality of life measured using EQ -5D -5L 06 months after randomization. Change in quality of life measured using EQ 5D 5L 02 and 04 months after randomization. Changes in symptom burden using the Edmonton symptom assessment scale- renal version (ESAS-r)- renal 2, 4, and 6 months after randomization. The difference in the number of a patient completing advanced care planning discussion and preparedness for ACP using dyad congruence. Timepoint: 3 years

Countries

India

Contacts

Public ContactDrShankar Prasad N

Kasturba Medical College Manipal

shankar.prasad@manipal.edu9739905443

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026